924 material Form 8-K filings that 737 companies we cover made with the SEC in January 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Azenta, Inc. disclosed that director Alan P. Malus resigned from its Board of Directors effective January 29, 2026. The company said the resignation was not due to any disagreement and that Malus has taken a full-time role with another company that will limit his time for Azenta duties.
Alan P. Malus resigned from the Board effective January 29, 2026
He also served on the Human Resources and Compensation Committee
Company states no disagreement with Azenta or its Board on operations, policies, or practices
Resignation attributed to Malus assuming full-time responsibilities at another company
Rayonier closed its merger with PotlatchDeltic on January 30, 2026, converting each PotlatchDeltic share into 1.8185 Rayonier common shares and $0.61 in cash. The Rayonier board was reconstituted to ten directors, and the combined company will keep the Rayonier name and trade under RYN starting February 2, 2026.
Each PotlatchDeltic common share converted into 1.8185 Rayonier common shares plus $0.61 in cash
Rayonier issued approximately 140.9 million common shares in connection with the merger
Eric J. Cremers, former PotlatchDeltic CEO, became Executive Chairman for a two-year term; Scott R. Jones became Lead Independent Director
Mark D. McHugh will serve as President and CEO for a four-year term, with an annual base salary of $950,000
Helix Acquisition Corp. III, a blank check company, closed its initial public offering on January 26, 2026, selling 17,250,000 Class A ordinary shares at $10.00 per share for gross proceeds of $172.5 million, including the full exercise of the underwriters' over-allotment option. The full $172.5 million was placed in a U.S.-based trust account, and the company has 24 months to complete a business combination but has not yet selected a target, so shareholder funds remain in trust rather than in an operating business.
IPO closed January 26, 2026: 17,250,000 Class A ordinary shares at $10.00 each, including 2,250,000 from the over-allotment option, for $172.5 million gross proceeds.
Concurrent private placement of 497,500 Class A shares at $10.00 each to sponsor Helix Holdings III LLC, for $4.975 million gross proceeds.
$172.5 million placed in trust account, with Continental Stock Transfer & Trust Company as trustee.
Company has 24 months from the IPO closing to complete a business combination; no target has been selected.
Lafayette Digital Acquisition Corp. I, a blank check company, said holders of its units may separate them into Class A ordinary shares and warrants starting on or about February 4, 2026. Separated shares and warrants will trade on Nasdaq under ZKP and ZKPW, while units not separated continue to trade as ZKPU. The filing is administrative and does not describe a business combination or change in financial results.
Separate trading of Class A ordinary shares and warrants begins on or about February 4, 2026.
Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant.
Separated securities trade under ZKP (shares) and ZKPW (warrants); units not separated continue under ZKPU.
Unit holders must contact Continental Stock Transfer & Trust Company through their brokers to separate units.
IBM's board elected Ramon Laguarta, chairman and chief executive officer of PepsiCo, to its board of directors, effective March 1, 2026. He will join the Directors and Corporate Governance Committee, and the filing furnishes the related press release as Exhibit 99.1.
Ramon L. Laguarta, 62, is chairman and CEO of PepsiCo and has led the company since 2018.
Board election is effective March 1, 2026; he will join the Directors and Corporate Governance Committee.
Arvind Krishna, IBM chairman, president and CEO, said Laguarta's technology transformation background would help IBM deliver value to shareholders.
Legato Merger Corp. IV, a blank check company with no operations, completed its initial public offering on January 26, 2026, selling 23,000,000 units at $10.00 each for gross proceeds of $230,000,000. The $230,000,000 was placed in a trust account, and the company must complete an initial business combination within 24 months (or 27 months if a deal agreement is signed in that period), or redeem the public shares.
23,000,000 units sold at $10.00 each on January 26, 2026, including 3,000,000 over-allotment units exercised in full on January 23, 2026; gross proceeds of $230,000,000
Private placement of 550,000 units at $10.00 each for $5,500,000 to initial shareholders and IPO underwriters, completed simultaneously
$230,000,000 placed in trust account; transaction costs of $12,001,028 and $2,466,163 in cash held outside the trust
Company has until the end of its combination period (24 months, or 27 months with a signed agreement) to complete a business combination
Chevron's independent directors completed their annual review of executive pay on January 28, 2026, approving a $75,000 base salary increase for Chairman and CEO Michael K. Wirth and ratifying smaller raises for other named executive officers, effective March 1, 2026. The filing also covers incentive target percentages, which were left unchanged, and equity award values for 2026 grants, which shareholders may track in future proxy and SEC filings.
Wirth's annual base salary rises $75,000 to $1,975,000; CFO Eimear P. Bonner's rises $50,000 to $1,100,000
Mark A. Nelson's base salary rises $25,000 to $1,350,000; R. Hewitt Pate's rises $50,000 to $1,250,000
Target bonus percentages under the Chevron Incentive Plan are unchanged for 2026, including 165 percent for Wirth
Equity award values of $23,000,000 for Wirth, $5,094,000 for Bonner, $8,533,800 for Nelson and $7,641,000 for Pate, with a February 1, 2026 grant date
Becton Dickinson's board adopted an executive severance plan effective January 27, 2026, covering named executive officers and other eligible managers whose employment is terminated without cause. At its January 27, 2026 annual meeting, shareholders approved adding 3,935,000 shares to the 2004 equity-based compensation plan and approved all board nominees and the other proposals.
Severance plan: CEO receives 1.5x base salary and target bonus in a lump sum; Executive Leadership Team members receive 1.0x; Business Unit Presidents and other eligible participants receive 1.0x base salary.
Equity plan: shareholders approved an increase of 3,935,000 shares available for awards under the 2004 Plan.
Proposal 4 vote: 232,072,981 for, 8,310,708 against, 1,170,610 abstentions.
Ernst & Young ratified as independent auditor for fiscal 2026 with 240,467,316 votes for and 16,959,702 against.
Space Asset Acquisition Corp. closed its initial public offering on January 29, 2026, selling 23,000,000 units at $10.00 per unit for $230,000,000 in gross proceeds, including the full exercise of the underwriters' over-allotment option. The company placed $230,000,000 in a U.S.-based trust account, and those funds generally stay there until a business combination, a shareholder-approved redemption, or the return of funds to public shareholders within 24 months of the IPO closing if no combination is completed. For shareholders, the filing details how the capital was raised and the conditions that govern use of the trust funds.
IPO closed January 29, 2026: 23,000,000 units at $10.00 per unit, including 3,000,000 over-allotment units, for $230,000,000 in gross proceeds.
Private placement of 645,000 units at $10.00 per unit for $6,450,000; the Sponsor bought 415,000 units and BTIG, LLC bought 230,000 units.
$230,000,000 placed in a trust account maintained by Efficiency INC.; trust funds are generally not released before a business combination, a qualifying shareholder redemption, or 24 months after the IPO closing.
Eric Zahler, Anders Johnson and Celeste Ford were appointed independent directors on January 27, 2026; each received 25,000 Class B ordinary shares as director compensation.
X3 Acquisition Corp. Ltd. sold an additional 2,500,000 units on January 26, 2026, through a partial exercise of the underwriters' over-allotment option, for gross proceeds of $25 million. The filing says $225 million of IPO and private placement proceeds is now held in a trust account for public shareholders, and the balance sheet adjustments reflect that deposit.
Underwriters bought 2,500,000 over-allotment units at $10.00 per unit on January 26, 2026, for $25,000,000 in gross proceeds, out of up to 3,000,000 units allowed.
The sponsor, X3 Acquisition Management LLC, bought 375,000 additional private placement warrants at $1.00 each, for $375,000, and owes the company $375,000 for the related funds advanced.
A total of $225,000,000 from the IPO and private placements was placed in the trust account as of January 26, 2026.
The underwriters have 45 days from the January 22, 2026 IPO date to buy the remaining 500,000 units.
First Advantage Corporation disclosed that director Bianca Stoica resigned from its Board of Directors and the Compensation Committee, effective immediately, after notifying the Board on January 29, 2026. The filing states her resignation was not due to any disagreement with the company, its management, or the Board on operations, policies or practices. The filing does not name a successor or provide financial figures.
Bianca Stoica notified the Board of her resignation on January 29, 2026.
Resignation covers her seat on the Board and on the Compensation Committee, effective immediately.
The company states the resignation was not due to any disagreement on operations, policies or practices.
OPENLANE, Inc. disclosed that director Sanjeev Mehra resigned from its Board of Directors effective January 29, 2026. The company states the resignation was not related to any disagreement with it on operations, policies or practices.
Sanjeev Mehra notified the company of his board resignation on January 29, 2026, effective that day.
The filing states the resignation was not due to any disagreement with the company on operations, policies or practices.
The 8-K does not name a replacement director or describe board changes beyond this resignation.
Intuit entered a $5.8 billion unsecured short-term revolving credit facility with JPMorgan Chase Bank as administrative agent, maturing March 31, 2026. The company may use borrowings only to fund its early tax refund offering, which provides eligible customers access to federal refunds up to five days before IRS settlement. The company has not borrowed under the facility to date.
Mondelez International said CFO Luca Zaramella will also serve as Chief Operating Officer starting February 1, 2026, overseeing commercial operations in its four geographical regions and the corporate sales, marketing and supply chain functions. The company is searching for a successor for the CFO role and expects to announce one at a later date, so the leadership change is not yet complete for shareholders.
Zaramella, 56, has been CFO since August 2018 and joined the company in 1996.
Zaramella's COO role takes effect February 1, 2026, in addition to his CFO duties.
Approved 2026 pay: base salary of $1,250,000, target annual incentive of 150% of base salary, and long-term incentive target value of $7,225,000.
The company is conducting a search for a CFO successor and expects to announce one at a later date.
Power Integrations amended and restated its bylaws on January 27, 2026, updating stockholder meeting, nomination, and forum procedures. The Talent and Compensation Committee also raised the shares reserved under its inducement award plan by 500,000 to 850,000, adopted without stockholder approval for new hires. The filing describes governance procedures and equity grant capacity, not financial results.
Board amended and restated bylaws effective January 27, 2026, including universal proxy and stockholder nomination rules.
Bylaws now name the Delaware Court of Chancery and federal district courts as exclusive forums for certain proceedings.
Inducement plan shares reserved increased by 500,000 to a total of 850,000 shares of common stock.
Inducement plan awards are limited to individuals not previously employees or directors, adopted under Nasdaq Rule 5635(c)(4).
Robinhood's two broker-dealer subsidiaries, Robinhood Financial LLC and Robinhood Securities, LLC, furnished their Rule 606(a) order routing reports for the fourth quarter of 2025. The reports are unaudited, are made without commentary, and do not present Robinhood's consolidated results. The filing contains no consolidated earnings, revenue, or guidance figures.
Reports cover the fourth quarter of 2025 for Robinhood Financial LLC and Robinhood Securities, LLC, furnished as Exhibits 99.1 and 99.2.
The filing states the reports are unaudited, made without commentary, and should be read with Robinhood's Forms 10-Q and 10-K.
Robinhood Securities, LLC passes 80% of revenue from third-party market centers to Robinhood Financial LLC under a revenue and cost allocation agreement.
The filing lists Item 2.02 Results of Operations but refers to Item 7.01 and reports no financial results.
On January 28, 2026, Cullen/Frost's board elected Marsha M. Shields and Jeffrey M. Rummel as directors and expanded the board from thirteen to fifteen members. Director Chris Avery notified the company on January 27, 2026, that he will retire and not stand for re-election when his term expires at the 2026 annual meeting, scheduled for April 29, 2026. The filing contains no financial figures; the changes concern board composition and independence.
Marsha M. Shields and Jeffrey M. Rummel elected directors on January 28, 2026; board size raised from 13 to 15.
Chris Avery notified the company on January 27, 2026, of his retirement; his term ends at the annual meeting scheduled for April 29, 2026.
Rummel was managing partner of Ernst & Young's San Antonio office from 2020 to June 2025; Shields is CEO and Managing Partner of McCombs Enterprises.
Both new directors were determined to be independent and will serve on the Audit and Risk Committees; Shields has an ownership stake in entities with 2025 banking transactions with the company.
Source Capital said its average discount to net asset value stayed under 10% for 2025, so no tender offer will occur for that year. The board also extended the discount management program through 2027 and approved a contingent tender offer for 2027, which would be triggered only if the average discount exceeds 10%.
No 2025 tender offer, because the average discount to NAV for January 1 to December 31, 2025 was under 10%
Fund traded at a premium in Q4 2025, peaking at 1.20% above NAV on November 28, 2025
Program extended through December 31, 2027; a 2027 tender would cover 10% of outstanding shares at 98% of NAV if the average discount exceeds 10%
As of December 31, 2025, about 21.7% of NAV was in private credit, and about 25.9% of NAV including committed capital
SM Energy completed its all-stock merger with Civitas Resources on January 30, 2026, and the combined company will keep the SM ticker. The company also amended its credit agreement, raising lender commitments and the borrowing base and extending the facility's maturity, and it assumed Civitas's senior notes, which now add to its debt.
Both companies' stockholders approved the merger on January 27, 2026; Beth McDonald became CEO and the board grew to 11 members.
Revolving commitments rose from $2.0 billion to $2.5 billion, the borrowing base rose from $3.0 billion to $5.0 billion, and maturity was extended to January 30, 2031.
The company assumed five series of Civitas senior notes, with coupons from 5.000% to 9.625% and maturities from 2026 to 2033.
The company said it expects $200 million to $300 million in annual synergies and at least $1.0 billion in divestitures over the next year.
Illumina completed its acquisition of SomaLogic and related aptamer-based and functional proteomics assets from Standard BioTools on January 30, 2026, paying $350 million in cash at closing, subject to customary adjustments. The deal adds up to $75 million in potential milestone payments and royalties tied to product and service revenue, and Illumina said it funded the purchase with cash on hand. The filing does not give financial results for the acquired business, which Illumina said it will discuss on its February 5, 2026 earnings call.
Purchase price of $350 million in cash at closing, subject to customary adjustments
Up to $75 million in potential milestone payments to Standard BioTools, plus royalty streams
Transaction completed January 30, 2026; agreement dated June 22, 2025
Illumina will discuss the financial implications on its February 5, 2026 earnings call
Amgen and Kyowa Kirin signed a Termination Agreement on January 30, 2026, to end their License and Collaboration Agreement dated June 1, 2021. The termination takes effect only after regulatory approval is received, and the filing gives no financial terms or reasons.
Termination Agreement dated January 30, 2026 with Kyowa Kirin Co., Ltd.
Ends the License and Collaboration Agreement dated June 1, 2021
Termination is effective upon receipt of regulatory approval
Agreement filed as Exhibit 10.1; portions omitted as not material
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.